Related Experiment Video
Updated: Dec 24, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Extracorporeal Life Support: Four Decades and Counting
Omar S Alibrahim1, Christopher M B Heard2
11Department of Pediatrics, Division of Pediatric Critical Care, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo Women & Children's Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222 USA.
Extracorporeal life support (ECLS) offers temporary cardiorespiratory support for critically ill patients. Advances in ECLS technology have improved safety and efficacy over four decades, with increasing use in adults.
Area of Science:
- Cardiology
- Pulmonology
- Critical Care Medicine
- Biomedical Engineering
Background:
- Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is a vital technique for patients with cardiorespiratory failure.
- It functions as a heart-lung bypass, supporting patients for extended periods until recovery or transplantation.
- The evolution of ECLS technology over 40 years has led to significant improvements in safety, simplicity, and durability.
Purpose of the Study:
- To provide a comprehensive overview of the evolution of ECLS over the past four decades.
- To detail the application of ECLS in neonatal, pediatric, and adult populations.
- To describe the fundamental principles, circuit components, associated complications, and patient outcomes related to ECLS.
Main Methods:
- This review synthesizes information on the historical development and current state of ECLS.
- It examines trends in ECLS utilization across different age groups.
- The review includes a discussion of technological advancements and future directions in ECLS.
Main Results:
- Venoarterial (VA) and venovenous (VV) ECLS are the predominant modes of support.
- Neonatal respiratory ECLS use has decreased in the last 20 years.
- Adult respiratory ECLS use has increased, particularly following the 2009 H1N1 pandemic.
Conclusions:
- ECLS technology has advanced considerably, offering safer and more effective cardiorespiratory support.
- The application of ECLS varies significantly across pediatric and adult populations, with a notable rise in adult usage.
- Continued innovation in ECLS promises further improvements in patient outcomes for critical cardiorespiratory conditions.
More Related Videos
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Continuous Renal Replacement Therapy

